Document details for 'Pathogenic potential to humans of bovine Escherichia coli O26 in Scotland'

Authors Chase-Topping, M.E., Rosser, T., Allison, L.J., Courcier, E., Evans, J., McKendrick, I.J., Pearce, M.C., Handel, I., Caprioli, A., Karch, H., Hanson, M.F., Pollock, K.G.J., Locking, M., Woolhouse, M.E.J., Matthews, L., Low, J.C. and Gally, D.L.
Publication details Emerging Infectious Diseases 18(3), 439-448.
Keywords E. coli O26, E. coli O157, prevalence, PFGE, MLST, Nonmetric Multidimensional Scaling, NMS
Abstract Despite similar overall prevalences of E. coli O26 and O157 in Scottish cattle, human cases of shiga toxin-producing E. coli O26 infection are usually uncommon and clinically less severe. This discrepancy was investigated by genotyping cattle and human E. coli O26 isolates from Scotland and Europe. The genetic background of some Scottish strains was closely related to strains causing severe infections in Europe. Nonmetric multidimensional scaling found an association between hemolytic uremic syndrome (HUS) and multilocus sequence type ST21 strains and confirmed the importance of stx2 for severe human disease. Although the overall prevalence of E. coli O26 on Scottish cattle farms is equivalent to E. coli O157, prevalence of more virulent strains (stx2+ eae+) is low, reducing human infection risk. However, new data on E. coli O26-associated HUS cases in humans highlights the need for surveillance of non-O157 STEC and the importance and limiting factors for Stx2 phage acquisition.
Last updated 2013-09-12

Unless explicitly stated otherwise, all material is copyright © Biomathematics and Statistics Scotland.

Biomathematics and Statistics Scotland (BioSS) is formally part of The James Hutton Institute (JHI), a registered Scottish charity No. SC041796 and a company limited by guarantee No. SC374831. Registered Office: JHI, Invergowrie, Dundee, DD2 5DA, Scotland